SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IPIC
IPIC 0.00010000.0%Dec 18 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pancho Villa who wrote (716)9/23/1997 5:01:00 AM
From: far east   of 1359
 
Citicoline works. Mild stroke patients do recover gradually regardless of taking any medication. That is why there is statistically insignificance for mild stroke patients. However, for moderate to severe patients, Citicoline works very well.

IPIC should go back up gradually to 20-25 before FDA review of the drug. One thing to IPIC's advantage, there is currently no cure for stroke. Citicoline will be the only game in town for a while.

Redux is history. No one is going to remember it 1 year from now.

Focus on the future. It is a bargain at 13.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext